As we await the 2022-23 Final Budget Outcome, an analysis of forecast government spending on the pharmaceuticals sub-function reveals a potentially significant spike in topline growth. It also shows how Budget estimates for low or no growth can be very misleading because of what they do not include.
Final Budget Outcome will confirm the extent of topline PBS growth
September 18, 2023 Latest NewsBioPharma'The Facts'
Latest Video
New Stories
-
New partnership promotes buy local for homegrown innovation
May 8, 2025 - - Latest News -
New Zealand to change laws to promote medical conferences
May 8, 2025 - - Latest News -
Australia is about to get a new industry minister
May 8, 2025 - - Latest News -
Internal promotions for new generation of leaders at Astellas
May 7, 2025 - - Latest News -
New study reveals the far-reaching impact of ovarian cancer
May 7, 2025 - - Latest News -
Just the threat of tariffs has secured a quarter of a trillion in investment
May 7, 2025 - - Latest News -
Percheron Therapeutics launches bonus loyalty option offer
May 7, 2025 - - Australian Biotech